Most patients with acute osteomyelitis recover with no long-term complications if osteomyelitis is diagnosed promptly and treated adequately.
Management of osteomyelitis in dedicated units, with close multidisciplinary working, using evidence-based guidelines, may be associated with more efficient diagnostic work-up, a higher rate of identifying the causative organism, improved adherence to initial antibiotic recommendations with fewer antibiotic changes during treatment, and fewer relapses.[125]Copley LA, Kinsler MA, Gheen T, et al. The impact of evidence-based clinical practice guidelines applied by a multidisciplinary team for the care of children with osteomyelitis. J Bone Joint Surg Am. 2013 Apr 17;95(8):686-93.
http://www.ncbi.nlm.nih.gov/pubmed/23595066?tool=bestpractice.com
[126]Arias Arias C, Tamayo Betancur MC, Pinzón MA, et al. Differences in the clinical outcome of osteomyelitis by treating specialty: orthopedics or infectology. PLoS One. 2015;10(12):e0144736.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4683069
http://www.ncbi.nlm.nih.gov/pubmed/26678551?tool=bestpractice.com
Numerous published case series report that more than 90% of patients have infection-free limbs at 2 years or more after treatment.[111]Ferguson JY, Dudareva M, Riley ND, et al. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014 Jun;96-B(6):829-36.
http://www.ncbi.nlm.nih.gov/pubmed/24891586?tool=bestpractice.com
[113]McNally MA, Ferguson JY, Lau AC, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J. 2016 Sep;98-B(9):1289-96.
http://www.ncbi.nlm.nih.gov/pubmed/27587534?tool=bestpractice.com
[119]McNally MA, Small JO, Tofighi HG, et al. Two-stage management of chronic osteomyelitis of the long bones: the Belfast technique. J Bone Joint Surg Br. 1993 May;75(3):375-80.
http://www.ncbi.nlm.nih.gov/pubmed/8496203?tool=bestpractice.com
[122]Cierny G 3rd, DiPasquale D. Treatment of chronic infection. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S105-10.
http://www.ncbi.nlm.nih.gov/pubmed/17003180?tool=bestpractice.com
These series are from centres with established multidisciplinary teams that can deliver all aspects of treatment. The prognosis from early intervention is usually better, particularly in the context of implant-related infection. Delay in treating these patients is likely to worsen long-term outcomes. The functional outcome for osteomyelitis of the lower extremity depends on the status of the foot and knee.
The success of treatment of chronic osteomyelitis depends largely on the host class (A, B, or C according to the Cierny-Mader classification; see Classification).[2]Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003 Sep;(414):7-24.
http://www.ncbi.nlm.nih.gov/pubmed/12966271?tool=bestpractice.com
A study of 1966 patients showed that primary treatment was successful in 96% of class A hosts and 73% of class B hosts.[122]Cierny G 3rd, DiPasquale D. Treatment of chronic infection. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S105-10.
http://www.ncbi.nlm.nih.gov/pubmed/17003180?tool=bestpractice.com
Retreatment of the patients in whom treatment had failed gave a 95% success rate at 2 years for both class A and class B patients.
Recurrence of infection may occur early or late.[10]Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015 Sep 15;61(6):e26-46.
https://academic.oup.com/cid/article/61/6/e26/452579
http://www.ncbi.nlm.nih.gov/pubmed/26229122?tool=bestpractice.com
[127]Garcia Del Pozo E, Collazos J, Carton JA, et al. Factors predictive of relapse in adult bacterial osteomyelitis of long bones. BMC Infect Dis. 2018 Dec 7;18(1):635.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6286499
http://www.ncbi.nlm.nih.gov/pubmed/30526540?tool=bestpractice.com
[128]Clerc A, Zeller V, Marmor S, et al. Hematogenous osteomyelitis in childhood can relapse many years later into adulthood: a retrospective multicentric cohort study in France. Medicine (Baltimore). 2020 May;99(20):e19617.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7254121
http://www.ncbi.nlm.nih.gov/pubmed/32443285?tool=bestpractice.com
Early recurrence should prompt assessment of the adequacy of the antimicrobial regimen (spectrum of activity, dosage and penetration to the site of infection, and adherence) before deciding on the need to broaden the antimicrobial spectrum, restart antimicrobials, or consider the need for surgical intervention.[4]Woods CR, Bradley JS, Chatterjee A, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. J Pediatric Infect Dis Soc. 2021 Sep 23;10(8):801-44.
https://academic.oup.com/jpids/article/10/8/801/6338658
http://www.ncbi.nlm.nih.gov/pubmed/34350458?tool=bestpractice.com
[10]Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015 Sep 15;61(6):e26-46.
https://academic.oup.com/cid/article/61/6/e26/452579
http://www.ncbi.nlm.nih.gov/pubmed/26229122?tool=bestpractice.com
Most patients who relapse have symptoms within the first 2 years after surgery.[127]Garcia Del Pozo E, Collazos J, Carton JA, et al. Factors predictive of relapse in adult bacterial osteomyelitis of long bones. BMC Infect Dis. 2018 Dec 7;18(1):635.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6286499
http://www.ncbi.nlm.nih.gov/pubmed/30526540?tool=bestpractice.com
Although recurrence becomes less likely with the passage of time, a few patients can relapse many years later.[129]Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother. 2003 May;51(5):1261-8.
http://www.ncbi.nlm.nih.gov/pubmed/12668581?tool=bestpractice.com